Cetuximab and/or Dasatinib in Patients With Colorectal Cancer and Liver Metastases That Can Be Removed by Surgery

Clinical trial NCT00835679 · TERMINATED

Trial details

NCT number: NCT00835679
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Liver Metastases Mucinous Adenocarcinoma of the Colon Mucinous Adenocarcinoma of the Rectum Recurrent Colon Cancer Recurrent Rectal Cancer Signet Ring Adenocarcinoma of the Colon Signet Ring Adenocarcinoma of the Rectum Stage IV Colon Cancer Stage IV Rectal Cancer

Start date: 2009-12-01
Primary completion: 2011-02-01
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.